Anticonvulsant drugs Flashcards
(37 cards)
Barbiturate drugs
Phenobarbital
Benzodiazepine drugs
lorazepam
Seizure
episode of neurologic dysfunction (abnormal neuronal firing) manifest by changes in motor control, sensory perception, behavior, and/or autonomic dysfunction
Epilepsy
recurrent spontaneous seizures arising from aberrant electrical activity in the brain
Occurrence of unprovoked seizures separated by 24 hours
Seizure types
Focal- seizure activity starts in one area of the brain
Generalised- seizure activity involves both hemispheres of the brain (absence, tonic clonic, myoclonic, clonic, tonic, atonic)
and Unknown (epileptic spasm, others)
Focal (Partial) Seizures
Aware (simple partial)
Impaired awareness (complex partial)
Secondarily generalized
Generalized
Tonic-clonic (grand mal)
Absence (petit mal)
Myoclonic
Atonic
Pathophysiology: Excessive excitation or disordered inhibition:
Small number of neurons fire abnormally
Membrane conductance and inhibitory currents break down
Excess excitability spreads
Locally (focal) or more widely (generalized)
Pathophysiology: Multiple mechanisms:
Altered ion channels
Receptor modification
Alteration in 2nd messaging
Changes in extracellular ion concentrations
Abnormal neurotransmitter uptake & metabolism
Shift in ratio/function of inhibitory circuits
Antiepileptic Drug (AED) Mechanisms of Action
Limit sustained, repetitive firing of neurons, mediated by promoting the inactivated state of voltage-gated Na+ channels
Enhanced γ-aminobutyric acid (GABA) mediated synaptic inhibition, mediated by presynaptic or postsynaptic actions
Inhibition of voltage-gated Ca2+ channels
drugs that enhance Na+ channel inactivation
carbamazepine, phenytoin, topiramate
lamotrigine, valproate, zonisamide
(anti-focal seizures)
drugs that enhance GABA synaptic transmission
vigabatrin, valproate, tiagabine (pre-synaptic)
benzodiazepines, barbiturates (post-synaptic)
drugs thatt reduce Ca2+ channel current
valproate, ethosuximide
anti-absence drugs
Basic Pharmacology of AEDs- Pharmacokinetics:
Absorption 80-100%
Most not highly protein bound
- Exception: phenytoin, tiagabine, valproic acid
Hepatic metabolism
Slow plasma clearance
Some have long t1/2 > 12 hours
Common Adverse Drug Reactions
Neurotoxic Effects: Sedation Dizziness Blurred or double vision Difficulty concentrating Ataxia
Phenytoin MOA, PK, uses, ADRs
MOA: * prolongs inactivated state of Na+ channel
– Decreases synaptic release of glutamate and enhances release of GABA
PK: * highly protein bound
- Dose-dependent elimination
- CYP2C9 and CYP2C19 metabolism
- Fosphenytoin (phosphate ester prodrug)
Focal seizures, generalized tonic-clonic
Unique ADRs: * gingival hyperplasia, hirsutism
– Cardiac effects: hypotension, bradycardia, arrhythmia
Carbamazepine
MOA: * prolongs inactivated state of Na+ channel
– Decrease presynaptic release of glutamate
PK: * potent CYP inducer
– Autoinduction t1/2 36 hours –> 8-12 hours after cont. therapy
Focal seizures, generalized tonic-clonic, trigeminal neuralgia, mania in bipolar disorder
Unique ADRs: * hyponatremia, blood dyscrasias (agranulocytosis), * leukopenia, SJS (Asian descent esp.)
Lamotrigine
MOA: * prolongs inactivated state of Na+ channel
– Also inhibits voltage-gated Ca2+ channels
Focal seizures, generalized tonic-clonic, bipolar disorder
Unique ADRs: *skin rash
Valproic Acid
MOA: * prolongs inactivated state of Na+ channel, may block NMDA receptor mediated excitation, may increase levels of GABA
PK: * highly protein bound
Absence seizures, myoclonic seizures, generalized tonic-clonic, focal seizures, status epilepticus, bipolar disorder, migraine prophylaxis
Unique ADRs: GI distress, * fine tremor, weight gain, hair loss
– Hepatotoxicity, thrombocytopenia
Topiramate
MOA: actions on * Na+ channels, * GABAA receptors, high-voltage * Ca2+ currents, may act on *glutamate/NMDA receptors
Focal, generalized tonic-clonic, Lennox-Gastaut, infantile spasms, absence seizures, migraine
Unique ADRs: *paresthesias, nervousness, *weight loss
Benzodiazepines and Barbiturates
Diazepam:
MOA: enhance * GABA-mediated Cl- influx and enhance the generation of inhibitory membrane potentials
PK: * extremely lipophilic
Status epilepticus, myoclonic, focal, generalized tonic-clonic seizures
Phenobarbital
MOA: * enhances GABA mediated current and can also decrease excitatory responses (glutamate release)
PK: * hepatic enzyme inducer
Focal seizures, generalized tonic-clonic
Gabapentin
MOA: bind α2δ subunit of voltage-gated N-type Ca2+ channels, *decrease Ca2+ entry, decrease synaptic release of glutamate
PK: * not metabolized
Focal seizures, generalized tonic-clonic, neuropathic pain, post-herpetic neuralgia
Unique ADRs: headache, tremor
Levetiracetam
MOA: binds * synaptic vesicular protein SV2A. Modifies synaptic release of glutamate and GABA.
Focal seizures, generalized tonic-clonic, myoclonic seizures
Unique ADRs: * serious mood and behavioral changes (less common)
Ethosuximide
MOA: reduces low threshold * Ca2+ (T-type) current
PK: long t1/2 40 hours
* Absence seizures
Unique ADRs: * gastric distress